Eratos Therapeutics
PrivateLast Round
Accelerator
Feb 9, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eratos Therapeutics is a drug discovery company leveraging generative AI to identify new targets and develop CNS therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Mental Health
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eratos Therapeutics Comparables
Compare Eratos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exin Therapeutics | 86% | |
| Forecast Bio, Inc. | 84% | |
| Bexorg | 80% | |
Eratos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 9, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2026
Completed an Accelerator round of funding.
Eratos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eratos Therapeutics's valuation, stock price, and market status.